Vimarsana
Biggest News Aggregation in the World

Page 2 - Express Genes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Express Genes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Express Genes Today - Breaking & Trending Today

15 Stocks That Will Outperform the S&P 500 in 2024 - Vimarsana News

15 Stocks That Will Outperform the S&P 500 in 2024

In this article, we will take a detailed look at the 15 Stocks That Will Outperform the S&P 500 in 2024. For a quick overview of such stocks, read our article 5 Stocks That Will Outperform the S&P ...

Twist Bioscience Expands Express Genes Rapid Synthesis Service - Vimarsana News

Twist Bioscience Expands Express Genes Rapid Synthesis Service

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express...

Stocks making the biggest moves before the bell: SAVE, TSLA, TDOC, RIVN and more - Vimarsana News

Stocks making the biggest moves before the bell: SAVE, TSLA, TDOC, RIVN and more

These are the stocks posting the largest moves in premarket trading.

Source: cnbc.com
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion - Twist Bioscience (NASDAQ:TWST) - Vimarsana News

Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion - Twist Bioscience (NASDAQ:TWST)

Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing revenue and profit margins.

Twist Bioscience Corporation (NASDAQ:TWST) Q4 2023 Earnings Call Transcript - Vimarsana News

Twist Bioscience Corporation (NASDAQ:TWST) Q4 2023 Earnings Call Transcript

Twist Bioscience Corporation (NASDAQ:TWST) Q4 2023 Earnings Call Transcript November 17, 2023 Twist Bioscience Corporation beats earnings expectations. Reported EPS is $-0.81, expectations were $-0.94. Operator: Welcome to the Twist Bioscience’s Fiscal 2023 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that […]

Source: yahoo.com